FR2838646A1 - Cosmetic composition for improving skin tone, especially useful for female breast care, comprises clover extract and yam extract - Google Patents
Cosmetic composition for improving skin tone, especially useful for female breast care, comprises clover extract and yam extract Download PDFInfo
- Publication number
- FR2838646A1 FR2838646A1 FR0205025A FR0205025A FR2838646A1 FR 2838646 A1 FR2838646 A1 FR 2838646A1 FR 0205025 A FR0205025 A FR 0205025A FR 0205025 A FR0205025 A FR 0205025A FR 2838646 A1 FR2838646 A1 FR 2838646A1
- Authority
- FR
- France
- Prior art keywords
- extract
- cosmetic composition
- composition
- yam
- phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0208—Tissues; Wipes; Patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/11—Encapsulated compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Cosmetics (AREA)
Abstract
Description
dans l'alimentation.in food.
Composition cosmetique pour tonifier le buste Wile se rapporte au domaine de la cosmetique et plus particulierement a des compositions destinees au vein du buste chez la femme. Wile a pour objet de nouvelles compositions cosmetiques destinees a etre appliquees sur la peau directement, ou indirectement par l'intermediaire d'un moyen d'application impregne de cette composition et fixe sur un element de l'habillage feminin. La composition cosmetique comporte plusieurs extraits de plantes a action du type cestrogene, et un extrait de plante stimulant les cellules mammaires. La composition est de preference utilisee pour des Cosmetic composition for toning the bust Wile relates to the field of cosmetics and more particularly to compositions intended for the vein of the bust in women. Wile relates to new cosmetic compositions intended to be applied to the skin directly, or indirectly by means of a means of application impregnated with this composition and fixed on an element of women's clothing. The cosmetic composition comprises several plant extracts with an estrogen-like action, and a plant extract stimulating breast cells. The composition is preferably used for
veins de beaute corporelle.veins of bodily beauty.
Dans l'etat de la technique, on conna^t de l'enseignement du document FRA-2 780 885, des pieces de tissue adhesives munies d'un moyen adhesif pour etre retenue sur un element de l'habillage. Cet element concerne des articles de textiles, et notamment des articles de lingerie ou de bonneterie. Ces elements vent enduits d'une composition a base d'un extrait de plante a action de type cestrogene et d'un extrait de la plante Kigelia africana, les deux etant presentes sous la forme d'une composition a haute ., vscoste. Les pieces de tissue adhesives de ltetat de la technique posent un probleme car elles doivent imperativement etre detachees de i'article de textile pour permettre de nettoyer cet article de textile aussi souvent qu'il est souhaitable. En effet, les pieces de tissue adhesives vent simplement impregnees directement avec la composition visqueuse comportant les principes actifs. L'adhesion entre la composition visqueuse et le tissu ne tient In the state of the art, we know from the teaching of document FRA-2,780,885, pieces of adhesive tissue provided with an adhesive means for being retained on an element of the covering. This element relates to textile articles, and in particular lingerie or hosiery articles. These elements are coated with a composition based on a plant extract with estrogen-like action and an extract of the Kigelia africana plant, both being present in the form of a high composition. Adhesive tissue pieces of the prior art pose a problem because they must imperatively be detached from the textile article to allow cleaning of this textile article as often as is desirable. In fact, the pieces of adhesive tissue are simply impregnated directly with the viscous composition comprising the active ingredients. The adhesion between the viscous composition and the fabric does not hold
qu'au fait que la composition visqueuse en devient collante. that the viscous composition becomes sticky.
Mais au cours des processus de nettoyage, on place le tissu dans l'eau, et alors la composition visqueuse se dilue et devient de plus en plus fluide, ce qui contribue a son decrochement du tissu support. II est done imperatif de decrocher ces pieces de tissue enduites avant nettoyage, et de But during the cleaning processes, the fabric is placed in water, and then the viscous composition dilutes and becomes more and more fluid, which contributes to its detachment from the support fabric. It is therefore imperative to unhook these coated pieces of fabric before cleaning, and to
les fixer en-quite.fix them entirely.
L'invention a pour but de resoudre ce probleme en proposant une piece de tissu dans laquelle le principe actif de la composition cosmetique est presente a l'interieur de.capsules greffees sur la piece de tissu, ce qui permet de laisser les pieces de tissue fixees sur le vetement meme au cours The object of the invention is to solve this problem by proposing a piece of fabric in which the active principle of the cosmetic composition is present inside the capsules grafted onto the piece of fabric, which makes it possible to leave the pieces of tissue fixed on the garment even during
de son nettoyage.of its cleaning.
En effet, on choisit de preference de presenter le principe actif sous la forme d'une emulsion, ou sous la forme d'une solution liposoluble. L'emulsion est de preference du type eau dans huile. Ainsi le principe actif est inclus dans des microspheres se formant naturellement, de telle sorte que des parois de ces microspheres se forment a partir de composes lipidiques. Les composes lipidiques choisis vent de preference l'isohexadecane et ou le Indeed, it is preferably chosen to present the active principle in the form of an emulsion, or in the form of a liposoluble solution. The emulsion is preferably of the water in oil type. Thus the active principle is included in naturally occurring microspheres, so that walls of these microspheres are formed from lipid compounds. The lipid compounds chosen are preferably isohexadecane and or
PEG30 dipolyhydroxystearate.PEG30 dipolyhydroxystearate.
Dans le cas ou le principe actif est de preference encapsule, une paroi d'encapsulation est par exemple obtenue a partir de polyuree. Wile a une affinite particuliere avec le moyen d'application, support, sur lequel elle est retenue, ce support correspondent a la piece de tissu presentee sur ['element d'hab il lag e. Le su pport est dans des modes de real isation prefere real ise a In the case where the active principle is preferably encapsulated, an encapsulation wall is for example obtained from polyurea. Wile has a particular affinity with the means of application, support, on which it is retained, this support correspond to the piece of fabric presented on the element of clothing. Su pport is in preferred real isation modes
partir de fibres, ou sous forme de coussinets cellulosiques. from fibers, or in the form of cellulosic pads.
Le support de ['invention ne necessite pas de bande adhesive, il peut etre directement glisse dans une poche interieure deja formee dans ltelement d'habillage, et y etre laisse meme lorsque celui-ci est soumis au ravage. Les capsules etant hydrophobes, elles ne liberent pas dans lteau de ravage le principe actif. Et les capsules elles-memes restent fixees dans le support car les lipides de la paroi presentent des terminaisons permettant une bonne The support of the invention does not require an adhesive strip, it can be slid directly into an interior pocket already formed in the covering element, and be left there even when the latter is subjected to devastation. The capsules being hydrophobic, they do not release the active ingredient into the water. And the capsules themselves remain fixed in the support because the lipids of the wall have terminations allowing good
accroche sur les fibres ou la cellulose du support. grips on the fibers or cellulose of the support.
Enfin, le principe actif inclus dans ces capsules comporte de preference un extrait de trefle, presentant un fort taux d'isoflavones, et un extrait de Yam, qui est un precurseur de la DHEA. Cette association stimule les tissue mammaires, et permettent d'obtenir un rajounissement du buste se traduisant par une augmentation de la tonicite cellulaire. En effet, on observe une croissance de la synthese de collagene de 67% et une croissance de la synthese d'elastine de l'ordre de 68%. Dans un mode de realisation prefere la composition comporte egalement des extraits de Nigelle, de fenugrec, et de houblon, qui presentent des fonctions stimulantes de la lactation, et done les cellules mammaires. Cette composition apporte soutien et volume a la glance mammaire, en stimulant la tension superficielle de la peau et en Finally, the active ingredient included in these capsules preferably comprises an extract of clover, having a high level of isoflavones, and an extract of Yam, which is a precursor of DHEA. This association stimulates breast tissue, and makes it possible to obtain a rejuvenation of the bust, resulting in an increase in cellular tone. Indeed, we observe a growth of the synthesis of collagen of 67% and a growth of the synthesis of elastin of the order of 68%. In a preferred embodiment, the composition also comprises extracts of Nigella, fenugreek, and hops, which exhibit stimulating functions of lactation, and therefore mammary cells. This composition provides support and volume to breast glance, stimulating the surface tension of the skin and
augmentant le volume du sein.increasing breast volume.
Cette composition peut etre utilisee pour une application topique This composition can be used for topical application
directe, sans necessiter d'etre au prealable encapsulee. direct, without having to be previously encapsulated.
Suite a des examens cliniques pratiques sur des volontaires, on obtient avec la composition de ['invention des ameliorations de la fermete du buste, de la fermete cutanee et de l'elasticite cutanee. Une amelioration de l'ordre de 14% de la distance projetee entre mamelon et abdomen est obtenue. En parallele, on obtient une amelioration de plus de 70% de la longueur du pli du sein. De plus, le galbe du sein est ameliorb avec une augmentation observee de 13% de ['angle d'ouverture du sein, ce qui Following practical clinical examinations on volunteers, the composition of the invention provides improvements in firmness of the bust, skin firmness and skin elasticity. An improvement of the order of 14% of the projected distance between nipple and abdomen is obtained. In parallel, we get an improvement of more than 70% of the length of the breast fold. In addition, the curve of the breast is improved with an observed increase of 13% in the angle of opening of the breast, which
correspond a un redressement du sein, et a une diminution de la ptose. corresponds to a straightening of the breast, and a decrease in ptosis.
L'angle d'ouverture du sein correspond a un angle determine entre deux segments, le premier segment reliant ltextremite du mamelon a ['abdomen, et The angle of opening of the breast corresponds to a determined angle between two segments, the first segment connecting the end of the nipple to the abdomen, and
le deuxieme segment reliant cette meme extremite du mamelon au buste. the second segment connecting this same end of the nipple to the bust.
Cet angle est d'autant plus important que le sein est releve. This angle is all the more important as the breast is raised.
Une application de cette composition cosmetique est notamment conseillee apres un accouchement, apres une cure d'amaigrissement, ou au An application of this cosmetic composition is especially recommended after childbirth, after a weight-loss treatment, or at
cours de la menopause.during menopause.
Une composition cosmetique selon ['invention comporte un melange A cosmetic composition according to the invention comprises a mixture
de principes actifs dont les proportions massiques suivantes vent respectees. active ingredients whose following mass proportions are respected.
Extrait de trefle 1 a 70% Extrait de Yam 1 a 45 % Extrait de Fenugrec 1 a 35% Extrait de Nigelle 1 a 30% Extrait de Houblon 1 a 45% L'extrait de trefle correspond a un extrait vegetal obtenu a partir de frifolium prafense. II est de preference presente dans son solvent d'extraction, par exemple lteau, le propylene glycol, le butylene glycol, la glycerine, le polyethylene glycol, les ethers methyliques ou ethyliques des diglycols, les polyols cycliques, les diglycols ethoxyles ou propoxyles, les alcools (methanol, ethanol, propanol, butanol) ou tout melange de ces solvents. Selon un mode de realisation, I'extrait de trefle comporte: - un extrait sec de trefle representant 20% de la masse ponderale - la phase solvent represente 80% de la masse, et comporte une proportion de l'ordre de 47% en alcool et une proportion de ltordre de 53% d'eau. L'extrait de Yam correspond a un extrait vegetal obtenu a partir des racines de Discorea Villosa sauvages. L'extrait de Yam est de preference Clover extract 1 to 70% Yam extract 1 to 45% Fenugreek extract 1 to 35% Nigella extract 1 to 30% Hops extract 1 to 45% Clover extract corresponds to a plant extract obtained from frifolium prafense. It is preferably present in its extraction solvent, for example water, propylene glycol, butylene glycol, glycerin, polyethylene glycol, methyl or ethyl ethers of diglycols, cyclic polyols, ethoxylated or propoxylated diglycols, alcohols (methanol, ethanol, propanol, butanol) or any mixture of these solvents. According to one embodiment, the clover extract comprises: - a dry clover extract representing 20% of the weight mass - the solvent phase represents 80% of the mass, and comprises a proportion of the order of 47% in alcohol and a proportion of around 53% water. Yam extract corresponds to a plant extract obtained from the roots of wild Discorea Villosa. Yam extract is preferably
presente dans un solvent d'extraction, par exemple de lthydroxyglycol. present in an extraction solvent, for example hydroxyglycol.
L'extrait de Yam, selon un mode de realisation, comporte: - un extrait sec de Yam representant 20% de la masse - la phase solvent represente 80% de la masse, et comporte une proportion de l'ordre de 50% en Butylene Glycol, une proportion de l'ordre The Yam extract, according to one embodiment, comprises: - a dry Yam extract representing 20% of the mass - the solvent phase represents 80% of the mass, and comprises a proportion of the order of 50% in Butylene Glycol, a proportion of the order
% de glycerine et une proportion de l'ordre de 40% d'eau. % glycerin and a proportion of the order of 40% water.
L'extrait de Fenuprec correspond a un extrait des graines d'une legumineuse, plus particulierement de la souche Trigonella foenum graecoum. L'extrait de Fenugrec est de preference presente dans un solvent d'extraction, par exemple de lthydroxyglycol. L'extrait de Fenuprec, selon un mode de realisation, comporte: - un extrait sec de Fenugrec representant 15% de la masse, et - la phase solvent represente 80% de la masse, et comporte du The extract from Fenuprec corresponds to an extract from the seeds of a legume, more particularly from the Trigonella foenum graecoum strain. Fenugreek extract is preferably present in an extraction solvent, for example hydroxyglycol. The Fenuprec extract, according to one embodiment, comprises: - a dry extract of Fenugreek representing 15% of the mass, and - the solvent phase represents 80% of the mass, and comprises
Butylene Glycol.Butylene Glycol.
L'extrait de Nigelle est obtenu a partir des graines d'une renonculacees, du type Nigella Sativa, egalement connue sous les noms de Cumin noir ou de Nigelie cultivee. L'extrait de Nigelle est de preference Nigella extract is obtained from the seeds of a buttercup, of the Nigella Sativa type, also known as black cumin or cultivated Nigelie. Nigella extract is preferably
presente dans un solvent d'extraction, par exemple de l'hydroxyglycol. present in an extraction solvent, for example hydroxyglycol.
L'extrait de Nigelle, selon un mode de realisation, comporte: - un extrait sec de Nigelle representant 15% de la masse, et - la phase solvent represente 80% de la masse, et comporte du Nigella extract, according to one embodiment, comprises: - a dry Nigella extract representing 15% of the mass, and - the solvent phase represents 80% of the mass, and comprises
Butylene Glycol.Butylene Glycol.
L'extrait de houblon est obtenu a partir des inflorescences femelles de la souche Humulus Lupulus. L'extrait de Houblon est de preference presente The hop extract is obtained from the female inflorescences of the Humulus Lupulus strain. Hop extract is preferably present
dans un solvent d'extraction, par exemple de l'hydroxyglycol. in an extraction solvent, for example hydroxyglycol.
La composition cosmetique comportant un melange de principes actifs tels que decrits ci-dessus, et est de preference utilisee dans un gel destine a une application sur le buste de la femme. Les caracteristiques et avantages The cosmetic composition comprising a mixture of active principles as described above, and is preferably used in a gel intended for application to the woman's bust. Features and benefits
de la presente invention apparatront plus en detail dans la description qui of the present invention will appear in more detail in the description which
suit, relative a une forme preferentielle de realisation. Dans cet exemple, les follows, relating to a preferential form of realization. In this example,
parties et pourcentages vent exprimes en poids, sauf indication contraire. parts and percentages expressed in weight, unless otherwise indicated.
Exemple 1 de melanne de principes actifs Selon un mode particulier de realisation du melange de principes actifs, la composition suivante est plus particulierement realisee dans laquelle on fabrique le melange de principes actifs en respectant les proportions suivantes: Extrait de trefle 59,5 % Extrait de Yam 10 % -Extrait de Fenugrec 15% Extrait de Nigelle 15% Extrait de phenonip 0,5 % Dans un tel melange de principes actifs, on ajoute un conservateur, par exemple le phenonip, pour garantir la bonne conservation du melange et le maintien de l'activite de chacun des principes actifs. Le phenonip correspond a un melange de phenoxyethanol, de methylparaben, de Example 1 of a mixture of active principles According to a particular embodiment of the mixture of active principles, the following composition is more particularly produced in which the mixture of active principles is produced in accordance with the following proportions: Clover extract 59.5% Extract of Yam 10% - Fenugreek extract 15% Nigella extract 15% Phenonip extract 0.5% In such a mixture of active principles, a preservative is added, for example phenonip, to guarantee the good conservation of the mixture and the maintenance of the activity of each of the active ingredients. Phenonip corresponds to a mixture of phenoxyethanol, methylparaben,
butylparaben, d'ethylparaben et de propylparaben. butylparaben, ethylparaben and propylparaben.
Exemple 2 d'utilisation dun melanne de princines actifs Par exemple, ce melange de principes actifs peut etre utilise sous forme de gel pour une application directe sur les zones a traiter. Dans ce cas, on procede au etapes suivantes, pour former le gel. A cet effet, on prepare une composition active pour le traitement du buste en operant comme indique ci dessous, en utilisant les techniques usuelles de l'industrie des produits cosmetiques et dermatologiques. La composition ponderale est Example 2 of the use of a mixture of active principles For example, this mixture of active principles can be used in the form of a gel for direct application to the areas to be treated. In this case, the following steps are carried out to form the gel. To this end, an active composition for the treatment of the bust is prepared by operating as indicated below, using the usual techniques of the cosmetic and dermatological industry. The weight composition is
la suivante.the next one.
Premierement, on prepare une phase A en melangeant les composes de cette phase A sous agitation a vitesse moyenne, et a une temperature de C. L'arlacel P135 correspond a un emulsifiant eau dans huile, et comporte du PEG 30 Dipolyhydroxystearate. L'arlanol HD est un ester et comporte de l'isohexedecane. Le phenonip de la Phase A a toujours un role de conservateur, et permet ainsi d'obtenir une dose efficace de conservateur Firstly, a phase A is prepared by mixing the compounds of this phase A with stirring at medium speed and at a temperature of C. The Carlacel P135 corresponds to a water-in-oil emulsifier, and comprises PEG 30 Dipolyhydroxystearate. Arlanol HD is an ester and contains isohexedecane. The Phenonip of Phase A always has a role of preservative, and thus allows to obtain an effective dose of preservative.
dans le produit find.in the find product.
Phase A: Arlacel P135 2,00 g Arlanol HD 20,0 g Phenonip 0,23 g En parallele on prepare une phase B en solubilisant les composes de la phase C sous agitation moyenne, jusqu'a une solubilisation complete de ces composes dans l'eau soit atteinte. Le sulfate de magnesium de la phase Phase A: Arlacel P135 2.00 g Arlanol HD 20.0 g Phenonip 0.23 g In parallel, phase B is prepared by dissolving the compounds of phase C with moderate agitation, until complete dissolution of these compounds in water is reached. Phase magnesium sulfate
B correspond a un agent de cohesion de ['emulsion. B corresponds to a cohesion agent of the emulsion.
Phase B: MgS04, 7H20 0,70 g Eau 3,00 g Ensuite on verse le contenu de la phase B dans une phase C correspondent au melange de principes actifs obtenu selon l'exemple 1, sous Phase B: MgS04, 7H20 0.70 g Water 3.00 g Then the content of phase B is poured into phase C corresponding to the mixture of active principles obtained according to Example 1, under
agitation moyenne et a 40 C.moderate agitation and at 40 C.
Phase C: Melange de principe actif selon ltexemple 1 74,07 9 Le melange des phases A, B et C forme une solution dont le poids est de 100 grammes. Une partie de ce melange va ensuite etre utilise pour Phase C: Mixture of active principle according to example 1 74.07 9 The mixture of phases A, B and C forms a solution weighing 100 grams. Part of this mixture will then be used to
former une phase E dans les etapes ulterieures. form a phase E in the later stages.
En effet, dans une etape ulterieure, on prepare une phase D comportant les composes permettant la formation d'un gel comportant ces principes actifs. Cette phase D comporte du Titriplex lil qui comporte de l'EDTA, et qui est un chelateur de metaux et permet de limiter les phenomenes d'oxydation. Wile comporte du PVP K30 qui correspond a du polyvinyle pyrrolidone, et qui correspond a un agent fixant. Le capigel 98 comporte des acrylates et leurs copolymeres, il a un role gelifiant. Enfin In fact, in a subsequent step, a phase D is prepared comprising the compounds allowing the formation of a gel comprising these active ingredients. This phase D comprises Titriplex lil which comprises EDTA, and which is a metal chelator and makes it possible to limit the phenomena of oxidation. Wile contains PVP K30 which corresponds to polyvinyl pyrrolidone, and which corresponds to a fixing agent. Capigel 98 contains acrylates and their copolymers, it has a gelifying role. Finally
I'Hydrolithe 5 est un agent hydratant comportant du penthylene glycol. I'Hydrolithe 5 is a moisturizing agent comprising pentethylene glycol.
Phase D: Titriplex lil 0,10 g PVP K30 0,1Og Capigel 98 2,00 g Hydrolithe 5 5,00 9 Phase E: Melange de principes actifs (phases A+B+C) 10,00 g Phase F: Eau QSP 100 TEA 50 % en quantite suffisante pour obtenir un pH entre 5,5 et 6,5 Les composants des phases D et E vent incorpores a temperature ambiante sous agitation moyenne. La phase ainsi obtenue est completee jusqu'a 100 grammes avec de l'eau et homogeneisee. L'homogeneisation des phases permet diobtenir un gel lisse et dans lequel les principes actifs vent regulierement repartis. Le pH de ce melange est de plus corrige avec du TEA (triethanolamine) a 50% pour qu'une application topique sur la peau ne Phase D: Titriplex lil 0.10 g PVP K30 0.1Og Capigel 98 2.00 g Hydrolite 5 5.00 9 Phase E: Mixture of active ingredients (phases A + B + C) 10.00 g Phase F: Water QSP 100 TEA 50% in sufficient quantity to obtain a pH between 5.5 and 6.5 The components of phases D and E are incorporated at room temperature with moderate stirring. The phase thus obtained is completed up to 100 grams with water and homogenized. The homogenization of the phases makes it possible to obtain a smooth gel and in which the active ingredients are distributed regularly. The pH of this mixture is moreover corrected with TEA (triethanolamine) at 50% so that a topical application on the skin does not
cree pas de demangeaisons locales.creates no local itching.
Exemple 3 d'utilisation d'un melanne de principes actifs Dans cet exemple, on prevoit notamment d'encapsuler le melange de principes actifs decrit dans ltexemple 1, de maniere a ce qu'il soit presente sous une forme compatible avec le type de support sur lequel il sera ensuite Example 3 of the use of a mixture of active ingredients In this example, provision is made in particular to encapsulate the mixture of active ingredients described in example 1, so that it is present in a form compatible with the type of support. on which it will then be
presente (coussinet, mousse...).present (cushion, foam ...).
La methode d'encapsulation consiste en une polymerisation interfaciale in situ de resines aminoplastes. Dans une premiere etape on disperse une quantite suffisante de polymere, notamment de polyuree dans de l'eau. Les proportions vent telles que l'on obtient une dispersion du polymere dans lteau sous agitation. Ensuite, le principe actif sous une forme iiposoluble, par exemple celle de ltexemple 1, ou celle preparee dans la phase E de l'exemple 2, est incorpore sous forte agitation dans le melange The encapsulation method consists of an in situ interfacial polymerization of aminoplast resins. In a first step, a sufficient quantity of polymer, in particular polyurea, is dispersed in water. The wind proportions such that a dispersion of the polymer in water is obtained with stirring. Then, the active principle in an iiposoluble form, for example that of ltexample 1, or that prepared in phase E of example 2, is incorporated under strong agitation in the mixture
eau et polyuree.- Ainsi on obtient des gouttelettes les plus fines possibles. water and polyuree. - This produces the finest possible droplets.
Enfin, on procede par reaction in situe avec le reticulement de la resine Finally, we proceed by in situ reaction with the crosslinking of the resin
aminoplaste pour obtenir des formes de spheres autour des gouttelettes. aminoplast to form spheres around the droplets.
A cet effet, on prepare une composition active pour le traitement du buste en utilisant les techniques usuelles de l'industrie des produits To this end, an active composition is prepared for the treatment of the bust using the usual techniques of the product industry.
cosmetiques et dermatologiques.cosmetics and dermatology.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0205025A FR2838646B1 (en) | 2002-04-22 | 2002-04-22 | COSMETIC COMPOSITION FOR TONING THE BUST |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0205025A FR2838646B1 (en) | 2002-04-22 | 2002-04-22 | COSMETIC COMPOSITION FOR TONING THE BUST |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2838646A1 true FR2838646A1 (en) | 2003-10-24 |
FR2838646B1 FR2838646B1 (en) | 2004-07-02 |
Family
ID=28686259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0205025A Expired - Lifetime FR2838646B1 (en) | 2002-04-22 | 2002-04-22 | COSMETIC COMPOSITION FOR TONING THE BUST |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2838646B1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2855753A1 (en) * | 2003-06-03 | 2004-12-10 | Dermo Cosmologie Lab De | COMPOSITION BASED ON DIOSGENINE APPLICABLE TOPICALLY |
FR2872041A1 (en) * | 2004-06-25 | 2005-12-30 | Maurice Messegue Soc Par Actio | Agent for promoting cutaneous penetration of topically applied cosmetic or pharmaceutical active agents, comprising extract of cells of Ranunculaceae plant, especially lesser celandine |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2900573B1 (en) | 2006-05-05 | 2014-05-16 | Sederma Sa | NOVEL COSMETIC COMPOSITIONS COMPRISING AT LEAST ONE PEPTIDE CONTAINING AT LEAST ONE BLOCKED AROMATIC CYCLE |
FR2904549B1 (en) | 2006-08-03 | 2012-12-14 | Sederma Sa | COMPOSITION COMPRISING SARSASAPOGENIN |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2769502A1 (en) * | 1997-10-14 | 1999-04-16 | Sederma Sa | Cosmetic and dermopharmaceutical compositions containing a trefoil extract to counteract the dermal effects of the menopause |
FR2780885A1 (en) * | 1998-07-10 | 2000-01-14 | C3D Sarl | NEW HIGH VISCOSITY COSMETIC COMPOSITIONS FOR APPLICATION ON THE SKIN |
US6200594B1 (en) * | 1999-12-29 | 2001-03-13 | Vital Dynamics, Inc. | Breast-enhancing, herbal compositions and methods of using same |
FR2811563A1 (en) * | 2000-07-13 | 2002-01-18 | Oreal | COMPOSITION, ESPECIALLY COSMETIC, COMPRISING DHEA AND / OR A PRECURSOR OR DERIVATIVE, AND AT LEAST ONE COMPOUND INCREASING THE SYNTHESIS OF GLYCOSAMINOGLYCANS |
-
2002
- 2002-04-22 FR FR0205025A patent/FR2838646B1/en not_active Expired - Lifetime
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2769502A1 (en) * | 1997-10-14 | 1999-04-16 | Sederma Sa | Cosmetic and dermopharmaceutical compositions containing a trefoil extract to counteract the dermal effects of the menopause |
FR2780885A1 (en) * | 1998-07-10 | 2000-01-14 | C3D Sarl | NEW HIGH VISCOSITY COSMETIC COMPOSITIONS FOR APPLICATION ON THE SKIN |
US6200594B1 (en) * | 1999-12-29 | 2001-03-13 | Vital Dynamics, Inc. | Breast-enhancing, herbal compositions and methods of using same |
FR2811563A1 (en) * | 2000-07-13 | 2002-01-18 | Oreal | COMPOSITION, ESPECIALLY COSMETIC, COMPRISING DHEA AND / OR A PRECURSOR OR DERIVATIVE, AND AT LEAST ONE COMPOUND INCREASING THE SYNTHESIS OF GLYCOSAMINOGLYCANS |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2855753A1 (en) * | 2003-06-03 | 2004-12-10 | Dermo Cosmologie Lab De | COMPOSITION BASED ON DIOSGENINE APPLICABLE TOPICALLY |
WO2004108064A2 (en) * | 2003-06-03 | 2004-12-16 | Laboratoire De Dermo-Cosmologie | Diosgenin-based composition suitable for topical application |
WO2004108064A3 (en) * | 2003-06-03 | 2005-04-07 | Dermo Cosmologie Lab De | Diosgenin-based composition suitable for topical application |
FR2872041A1 (en) * | 2004-06-25 | 2005-12-30 | Maurice Messegue Soc Par Actio | Agent for promoting cutaneous penetration of topically applied cosmetic or pharmaceutical active agents, comprising extract of cells of Ranunculaceae plant, especially lesser celandine |
Also Published As
Publication number | Publication date |
---|---|
FR2838646B1 (en) | 2004-07-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0664112B1 (en) | Cosmetic and dermatological powder, its process for manufacturing and its use | |
JP5255449B2 (en) | Cellulose gel formulation | |
EP1265617A2 (en) | Novel topical oestroprogestational compositions with systemic effect | |
EP0771557B1 (en) | Use of ascorbic acid as the active agent for the treatment of seborrhea in a cosmetic and/or dermatalogical composition | |
WO1989008447A1 (en) | Liposomes containing scutellaria extracts | |
CN107206095A (en) | Percutaneous absorbtion base material containing lipid peptide type compound | |
JP2001524127A (en) | Emulsifier compositions for skin care formulations | |
WO2020084259A1 (en) | Novel cosmetic and dermatological uses of an extract from the fungus inonotus obliquus | |
FR2532546A1 (en) | PASTE FOR SKIN PROTECTION | |
KR101572155B1 (en) | Method of Manufacturing Natural Cosmetic Composition Containing the extract of Moringa oleifera | |
KR20190106713A (en) | A composition for beauty pack having rapidly water-melting and method for mixing thereof, and beauty pack using the same | |
FR3111795A1 (en) | CARE KIT FOR KERATINIC MATERIALS | |
FR2838646A1 (en) | Cosmetic composition for improving skin tone, especially useful for female breast care, comprises clover extract and yam extract | |
CN109528607A (en) | Skin barrier remediation composition and skin barrier repair product | |
KR20140141577A (en) | Personal care compositions with acidified pectins | |
JP2023085504A (en) | Emulsion composition for skin | |
EP2655420A1 (en) | Polysaccharide obtained from manihot esculenta, process for its obtention and use as cosmetic active principle as skin tensing agent | |
CN106619469A (en) | Couperose skin removal facial mask | |
KR100906696B1 (en) | Composite?powder comprising omega oil and stauntonia hexaphulla extracts | |
FR2780885A1 (en) | NEW HIGH VISCOSITY COSMETIC COMPOSITIONS FOR APPLICATION ON THE SKIN | |
CN110551352A (en) | simulated biological film and preparation method and application thereof | |
CN107708660A (en) | Include the bar-shaped base material of lipid peptide type compound | |
CA2731422C (en) | Cosmetic composition comprising an extract of chrysophyllum cainito | |
FR3086866A1 (en) | KIT COMPRISING TWO SEPARATE COMPOSITIONS, ESPECIALLY FOR A COSMETIC APPLICATION | |
JP2004161770A (en) | Use of silica-alumina composite filler for matting skins |